BridgeMD
New treatment option for Diverticulitis of Sigmoid
Official title Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis
ClinicalTrials.gov ID: NCT05942833
What this study is testing
- What it's testing
- Patients presenting in hospital with symptoms of acute diverticulitis. Acute inflammation of the left-sided colon is confirmed with CT scan or ultrasound in experienced centers and diagnosis is defined according to the "Classification of Diverticular Disease (CDD)".
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Informed consent to participate in the study
- CDD Type 2a, 2b: acute complicated left-sided diverticulitis
- CDD Type 3b: relapsing diverticulitis without complications (\>2 episodes within 2 years)
- Acute presentation
- Inflammation located in the left-sided colon
You likely can't join if
- \< 18 years
- Pregnancy
- BMI \> 55kg/m2
- Current colorectal carcinoma in the left-sided colon
- Oral and/or intravenous corticosteroid
- Ongoing chemotherapy
See the full eligibility criteria
- Informed consent to participate in the study
- CDD Type 2a, 2b: acute complicated left-sided diverticulitis
- CDD Type 3b: relapsing diverticulitis without complications (\>2 episodes within 2 years)
- Acute presentation
- Inflammation located in the left-sided colon
- Inflammation is CT proven or ultrasound confirmed from experienced radiologists
- \< 18 years
- Pregnancy
- BMI \> 55kg/m2
- Current colorectal carcinoma in the left-sided colon
- Oral and/or intravenous corticosteroid
- Ongoing chemotherapy
- Status post left hemicolectomy
- Patients who cannot take care of themselves at home or are unable to follow instructions
- Patients who are not fit for surgery (anesthesia, expert knowledge from specialists) and will not benefit from surgery
The study team makes the final eligibility decision.
Where it's taking place
- Linz, Austria, Austria
- Linz, Upper Austria, Austria
- Mannheim, Mannheim, Germany
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Linz, Austria, Austria; Linz, Upper Austria, Austria; Mannheim, Mannheim, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.